# Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate

> **NCT03990701** · EARLY_PHASE1 · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 25 (actual)

## Conditions studied

- Primary Aldosteronism
- Primary Aldosteronism Due to Aldosterone Producing Adenoma

## Interventions

- **COMBINATION_PRODUCT:** 11C-Metomidate PET/CT Scan

## Key facts

- **NCT ID:** NCT03990701
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-21
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-03-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990701, "Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03990701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*